Cheng P. Jiang

639 Longmian Avenue
Nanjing, 211198, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Discovery and characterization of PGC-01: An effective GSDMD-targeting PROTAC.

Discovery and characterization of PGC-01: An effective GSDMD-targeting PROTAC.

Journal: European journal of medicinal chemistry

Published: July 19, 2026

Differential cannabinoid-like effects, receptor affinity and physiologically based pharmacokinetics of the synthetic cannabinoids 4F-MDMB-BINACA, 4F-MDMB-BICA and 5F-MDMB-PICA in mice: A comparative study.

Differential cannabinoid-like effects, receptor affinity and physiologically based pharmacokinetics of the synthetic cannabinoids 4F-MDMB-BINACA, 4F-MDMB-BICA and 5F-MDMB-PICA in mice: A comparative study.

Journal: Toxicology and applied pharmacology

Published: August 12, 2025

Progress in small-molecule inhibitors of gasdermin D.

Progress in small-molecule inhibitors of gasdermin D.

Journal: European journal of medicinal chemistry

Published: August 05, 2025

Core competencies in pharmaceutical education: a Chinese student perspective.

Core competencies in pharmaceutical education: a Chinese student perspective.

Journal: BMC medical education

Published: March 25, 2025

Discovery of novel pyridine skeleton derivatives as potent CLK2/3 inhibitors.

Discovery of novel pyridine skeleton derivatives as potent CLK2/3 inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: October 17, 2024

Allosteric Activation of Protein Phosphatase 5 with Small Molecules.

Allosteric Activation of Protein Phosphatase 5 with Small Molecules.

Journal: Journal of medicinal chemistry

Published: August 15, 2024

Discovery of a Series of 4-Amide-thiophene-2-carboxyl Derivatives as Highly Potent P2Y14 Receptor Antagonists for Inflammatory Bowel Disease Treatment.

Discovery of a Series of 4-Amide-thiophene-2-carboxyl Derivatives as Highly Potent P2Y14 Receptor Antagonists for Inflammatory Bowel Disease Treatment.

Journal: Journal of medicinal chemistry

Published: July 03, 2024

Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis.

Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis.

Journal: Journal of medicinal chemistry

Published: June 18, 2024

A survey on improving core literacy among impoverished students in Chinese pharmaceutical universities under a development-oriented funding system.

A survey on improving core literacy among impoverished students in Chinese pharmaceutical universities under a development-oriented funding system.

Journal: BMC medical education

Published: April 11, 2024

Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors.

Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors.

Journal: Cytokine & growth factor reviews

Published: September 22, 2023

Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway.

Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway.

Journal: Cytokine & growth factor reviews

Published: September 12, 2023

Antimicrobial peptides: Structure, mechanism, and modification.

Antimicrobial peptides: Structure, mechanism, and modification.

Journal: European journal of medicinal chemistry

Published: March 03, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026